As a clinician he manages pain in children with developmental disabilities. As a researcher, his primary interest has been in studying how early life experiences shape stress/pain and related neurobehavioral outcomes during childhood. Dr. Oberlander’s work extends from molecular/genetic studies to population epidemiological studies that characterize neurodevelopmental pathways that reflect risk, resiliency and developmental plasticity. To this end, he has published pioneering studies on neurobehavioral outcomes in young children of depressed mothers who were treated with an SSRI antidepressant during pregnancy.